Trout 20myocytes


We make you stronger.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Rockville, MD, US
  • Currency USD
  • Founded August 2015
  • Employees 4
  • Incorporation Type C-corp
  • Website

Company Summary

AAVogen is a preclinical-stage biotech company that develops gene therapeutics for muscle wasting disease. The management team is well established with field-specific expertise and the science advisory board is internationally recognized. IND-enabling studies with proprietary technology are ongoing while CMC, regulatory and clinical plans have been completed.